SRXH Relative Valuation
SRXH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SRXH is overvalued; if below, it's undervalued.
Historical Valuation
Srx Health Solutions Inc (SRXH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Srx Health Solutions Inc (SRXH) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price:0.20
Fair
0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Srx Health Solutions Inc. (SRXH) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Srx Health Solutions Inc. (SRXH) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Srx Health Solutions Inc. (SRXH) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Srx Health Solutions Inc. (SRXH) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Srx Health Solutions Inc. (SRXH) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Srx Health Solutions Inc (SRXH) has a current Price-to-Book (P/B) ratio of 14.56. Compared to its 3-year average P/B ratio of 4.57 , the current P/B ratio is approximately 218.94% higher. Relative to its 5-year average P/B ratio of 4.57, the current P/B ratio is about 218.94% higher. Srx Health Solutions Inc (SRXH) has a Forward Free Cash Flow (FCF) yield of approximately -255.42%. Compared to its 3-year average FCF yield of -72.98%, the current FCF yield is approximately 249.99% lower. Relative to its 5-year average FCF yield of -72.98% , the current FCF yield is about 249.99% lower.
14.56
P/B
Median3y
4.57
Median5y
4.57
-255.42
FCF Yield
Median3y
-72.98
Median5y
-72.98
Competitors Valuation Multiple
The average P/S ratio for SRXH's competitors is 6.26, providing a benchmark for relative valuation. Srx Health Solutions Inc Corp (SRXH) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SRXH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of SRXH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is Srx Health Solutions Inc (SRXH) currently overvalued or undervalued?
Srx Health Solutions Inc (SRXH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Srx Health Solutions Inc (SRXH) is between to according to relative valuation methord.
What is Srx Health Solutions Inc (SRXH) fair value?
SRXH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Srx Health Solutions Inc (SRXH) is between to according to relative valuation methord.
How does SRXH's valuation metrics compare to the industry average?
The average P/S ratio for SRXH's competitors is 6.26, providing a benchmark for relative valuation. Srx Health Solutions Inc Corp (SRXH) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
What is the current P/B ratio for Srx Health Solutions Inc (SRXH) as of Jan 08 2026?
As of Jan 08 2026, Srx Health Solutions Inc (SRXH) has a P/B ratio of 14.56. This indicates that the market values SRXH at 14.56 times its book value.
What is the current FCF Yield for Srx Health Solutions Inc (SRXH) as of Jan 08 2026?
As of Jan 08 2026, Srx Health Solutions Inc (SRXH) has a FCF Yield of -255.42%. This means that for every dollar of Srx Health Solutions Inc’s market capitalization, the company generates -255.42 cents in free cash flow.
What is the current Forward P/E ratio for Srx Health Solutions Inc (SRXH) as of Jan 08 2026?
As of Jan 08 2026, Srx Health Solutions Inc (SRXH) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Srx Health Solutions Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Srx Health Solutions Inc (SRXH) as of Jan 08 2026?
As of Jan 08 2026, Srx Health Solutions Inc (SRXH) has a Forward P/S ratio of 0.00. This means the market is valuing SRXH at $0.00 for every dollar of expected revenue over the next 12 months.